• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯化的和重组大肠杆菌产生的志贺毒素在体外与糖脂的结合。

Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

作者信息

Lingwood C A, Law H, Richardson S, Petric M, Brunton J L, De Grandis S, Karmali M

出版信息

J Biol Chem. 1987 Jun 25;262(18):8834-9.

PMID:3298243
Abstract

Escherichia coli verotoxin (also known as Shiga-like toxin) has been implicated in the aetiology of the hemolytic uremic syndrome and hemorrhagic colitis. The glycolipid binding specificity of verotoxin purified from E. coli H30 and verotoxin cloned from bacteriophage H19B has been examined. Verotoxin from both sources binds specifically to globotriosyl ceramide containing the carbohydrate sequence galactose alpha 1-4galactose beta 1-4glucose-ceramide. Removal of the terminal galactose or substitution with N-acetylgalactosamine in beta 1-3 linkage deletes toxin binding activity. A ceramide trihexoside species, consistent with a globotriosyl ceramide structure was shown to be the major verotoxin-binding glycolipid of cultured vero cells which are routinely used to measure the cytotoxicity of toxin samples.

摘要

大肠杆菌维罗毒素(也称为志贺样毒素)与溶血性尿毒症综合征和出血性结肠炎的病因有关。对从大肠杆菌H30纯化的维罗毒素以及从噬菌体H19B克隆的维罗毒素的糖脂结合特异性进行了研究。来自这两种来源的维罗毒素都特异性结合含有碳水化合物序列半乳糖α1-4半乳糖β1-4葡萄糖-神经酰胺的球三糖基神经酰胺。去除末端半乳糖或以β1-3连接的N-乙酰半乳糖胺替代会消除毒素结合活性。一种与球三糖基神经酰胺结构一致的神经酰胺三己糖苷被证明是培养的非洲绿猴肾细胞的主要维罗毒素结合糖脂,这些细胞通常用于测量毒素样品的细胞毒性。

相似文献

1
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.纯化的和重组大肠杆菌产生的志贺毒素在体外与糖脂的结合。
J Biol Chem. 1987 Jun 25;262(18):8834-9.
2
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.球形三糖神经酰胺被大肠杆菌志贺毒素2特异性识别。
Biochem Biophys Res Commun. 1988 Apr 29;152(2):674-9. doi: 10.1016/s0006-291x(88)80091-3.
3
Verotoxin receptor glycolipid in human renal tissue.人肾组织中的维罗毒素受体糖脂
Nephron. 1989;51(2):207-10. doi: 10.1159/000185286.
4
Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.
Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S298-303. doi: 10.1093/clinids/13.supplement_4.s298.
5
pH-independent retrograde targeting of glycolipids to the Golgi complex.糖脂不依赖pH的逆向靶向至高尔基体复合体。
Am J Physiol. 1998 Feb;274(2):C319-32. doi: 10.1152/ajpcell.1998.274.2.C319.
6
Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.
J Lab Clin Med. 1992 Aug;120(2):229-38.
7
Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.α2干扰素结合的糖脂修饰。α2干扰素受体与维罗毒素(志贺样毒素)B亚基之间的序列相似性。
Biochem J. 1992 Apr 1;283 ( Pt 1)(Pt 1):25-6. doi: 10.1042/bj2830025.
8
Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.基于与志贺毒素及其天然受体球三糖神经酰胺(Gb3)结合的快速检测志贺毒素和志贺样毒素I的方法。
J Clin Microbiol. 1989 Jun;27(6):1145-50. doi: 10.1128/jcm.27.6.1145-1150.1989.
9
Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids.糖脂受体功能的脂质调节。天然和合成糖脂中用于维罗毒素结合的Gal(α1-4)Gal二糖的可及性。
Eur J Biochem. 1994 Aug 1;223(3):873-8. doi: 10.1111/j.1432-1033.1994.tb19064.x.
10
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.
J Biol Chem. 1987 Dec 15;262(35):17088-91.

引用本文的文献

1
Molecularly Defined Glycocalyx Models Reveal AB Toxins Recognize Their Target Glycans Superselectively.分子定义的糖萼模型揭示AB毒素超选择性识别其靶聚糖。
JACS Au. 2025 May 20;5(6):2699-2712. doi: 10.1021/jacsau.5c00305. eCollection 2025 Jun 23.
2
Advances in nanobody multimerization and multispecificity: from in vivo assembly to in vitro production.纳米抗体多聚化和多特异性的进展:从体内组装到体外生产。
Biochem Soc Trans. 2025 Feb 7;53(1):BST20241419. doi: 10.1042/BST20241419.
3
Single domain antibodies from camelids in the treatment of microbial infections.
骆驼科单域抗体在治疗微生物感染中的应用。
Front Immunol. 2024 May 17;15:1334829. doi: 10.3389/fimmu.2024.1334829. eCollection 2024.
4
Structure-Function Analysis of the A1 Subunit of Shiga Toxin 2 with Peptides That Target the P-Stalk Binding Site and Inhibit Activity.志贺毒素 2 亚单位 A1 的结构-功能分析与靶向 P 茎结合位点并抑制其活性的肽
Biochemistry. 2024 Apr 2;63(7):893-905. doi: 10.1021/acs.biochem.3c00733. Epub 2024 Mar 11.
5
Translocation across a human enteroid monolayer by zoonotic correlates with the presence of Gb3-positive cells.人畜共患病原体通过人肠道类器官单层的易位与Gb3阳性细胞的存在相关。
iScience. 2024 Feb 12;27(3):109178. doi: 10.1016/j.isci.2024.109178. eCollection 2024 Mar 15.
6
Shiga toxin 2 A-subunit induces mitochondrial damage, mitophagy and apoptosis via the interaction of Tom20 in Caco-2 cells.志贺毒素2 A亚基通过与Caco-2细胞中Tom20相互作用诱导线粒体损伤、线粒体自噬和细胞凋亡。
Heliyon. 2023 Sep 9;9(9):e20012. doi: 10.1016/j.heliyon.2023.e20012. eCollection 2023 Sep.
7
A unique peptide-based pharmacophore identifies an inhibitory compound against the A-subunit of Shiga toxin.一种独特的基于肽的药效团鉴定出一种抑制志贺毒素 A 亚基的化合物。
Sci Rep. 2022 Jul 6;12(1):11443. doi: 10.1038/s41598-022-15316-1.
8
A Macroporous Magnesium Oxide-Templated Carbon Adsorbs Shiga Toxins and Type III Secretory Proteins in Enterohemorrhagic , Which Attenuates Virulence.一种大孔氧化镁模板碳吸附肠出血性大肠杆菌中的志贺毒素和III型分泌蛋白,从而减弱其毒力。
Front Microbiol. 2022 May 6;13:883689. doi: 10.3389/fmicb.2022.883689. eCollection 2022.
9
Shiga Toxins and Gut Microbiota Interactions.志贺毒素与肠道微生物群相互作用。
Toxins (Basel). 2021 Jun 11;13(6):416. doi: 10.3390/toxins13060416.
10
Therapeutic Uses of Bacterial Subunit Toxins.细菌亚基毒素的治疗用途
Toxins (Basel). 2021 May 26;13(6):378. doi: 10.3390/toxins13060378.